Herseltpharma: what changed
What changed
Herseltpharma
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
€268,806
2024 · €95,906+€172,900
Equity
€920,049
2024 · €787,961+€132,089
Cash
€110,889
2024 · €107,792+€3,097
Balance sheet total
€1.3m
2024 · €1.5m-€215,674
Largest movements
Assets
- Tangible fixed assets -€119,279
down €119,279 (-77.8%), from €153,389 to €34,110
- Intangible fixed assets -€117,880
down €117,880 (-17.4%), from €676,924 to €559,043
- Stocks and contracts +€25,165
up €25,165 (+17.6%), from €142,707 to €167,872
Equity and liabilities
- Other debts -€241,652
down €241,652 (-93.8%), from €257,533 to €15,881
- Reserves +€132,089
up €132,089 (+26.7%), from €494,917 to €627,006
of which Distributable reserves: +€132,089
- Debts after one year -€95,366
down €95,366 (-49.2%), from €193,922 to €98,556
- Accrued charges and deferred income -€15,300
no longer reported in 2025 (was €15,300)
Income statement
- Gross operating margin +€258,350
up €258,350 (+45.9%), from €563,105 to €821,455
- Taxes +€80,143
up €80,143 (+135%), from €59,397 to €139,540
- Staff costs +€37,905
up €37,905 (+18.4%), from €205,581 to €243,487
- Financial charges -€18,993
down €18,993 (-33.8%), from €56,260 to €37,267
- Depreciation -€11,258
down €11,258 (-7.8%), from €145,207 to €133,949
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€95,906
Gross operating margin
+€258,350
Staff costs
-€37,905
Depreciation
+€11,258
Other operating charges
+€1,107
Financial income
+€1,241
Financial charges
+€18,993
Taxes
-€80,143
Result 2025
€268,806
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€129,548
Investment
+€107,370
Financing
-€233,821
Cash 2024
€107,792
From operations (derived)
+€129,548
Net result for the year
+€268,806
Depreciation
+€133,949
Stocks and contracts
-€25,165
Receivables within one year
+€3,632
Deferred charges and accrued income
-€1,016
Trade debts
-€4,848
Tax, wage and social debts
+€11,142
Other debts
-€241,652
Accrued charges and deferred income
-€15,300
Investment (derived)
+€107,370
Investment in fixed assets (net)
+€103,210
Current investments
+€4,160
Financing
-€233,821
Debts after one year
-€95,366
Current portion of long-term debt
-€1,738
Contributions, distributions and other
-€136,717
Cash 2025
€110,889
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,527,630 | €1,311,956 | -€215,674 | -14.1% |
| Fixed assets | 21/28 | €830,313 | €593,153 | -€237,160 | -28.6% |
| Intangible fixed assets | 21 | €676,924 | €559,043 | -€117,880 | -17.4% |
| Tangible fixed assets | 22/27 | €153,389 | €34,110 | -€119,279 | -77.8% |
| Land and buildings | 22 | €56,363 | - | -€56,363 | |
| Plant, machinery and equipment | 23 | €24,963 | €22,902 | -€2,060 | -8.3% |
| Furniture and vehicles | 24 | €19,368 | €11,207 | -€8,161 | -42.1% |
| Other tangible fixed assets | 26 | €52,695 | - | -€52,695 | |
| Current assets | 29/58 | €697,317 | €718,803 | +€21,486 | +3.1% |
| Stocks and contracts in progress | 3 | €142,707 | €167,872 | +€25,165 | +17.6% |
| Stocks | 30/36 | €142,707 | €167,872 | +€25,165 | +17.6% |
| Amounts receivable within one year | 40/41 | €166,329 | €162,697 | -€3,632 | -2.2% |
| Trade receivables | 40 | €164,688 | €160,891 | -€3,796 | -2.3% |
| Other amounts receivable | 41 | €1,641 | €1,806 | +€164 | +10.0% |
| Current investments | 50/53 | €250,095 | €245,936 | -€4,160 | -1.7% |
| Cash at bank and in hand | 54/58 | €107,792 | €110,889 | +€3,097 | +2.9% |
| Deferred charges and accrued income | 490/1 | €30,394 | €31,409 | +€1,016 | +3.3% |
| Total equity and liabilities | 10/49 | €1,527,630 | €1,311,956 | -€215,674 | -14.1% |
| Equity | 10/15 | €787,961 | €920,049 | +€132,089 | +16.8% |
| Contributions | 10/11 | €63,600 | €63,600 | = | 0.0% |
| Reserves | 13 | €494,917 | €627,006 | +€132,089 | +26.7% |
| Non-distributable reserves | 130/1 | €6,360 | €6,360 | = | 0.0% |
| Reserves not available under the articles | 1311 | €6,360 | €6,360 | = | 0.0% |
| Distributable reserves | 133 | €488,557 | €620,646 | +€132,089 | +27.0% |
| Profit (loss) carried forward | 14 | €229,444 | €229,444 | = | 0.0% |
| Amounts payable | 17/49 | €739,669 | €391,907 | -€347,763 | -47.0% |
| Amounts payable after more than one year | 17 | €193,922 | €98,556 | -€95,366 | -49.2% |
| Financial debts | 170/4 | €193,922 | €98,556 | -€95,366 | -49.2% |
| Amounts payable within one year | 42/48 | €530,447 | €293,351 | -€237,097 | -44.7% |
| Current portion of amounts payable after more than one year | 42 | €96,522 | €94,784 | -€1,738 | -1.8% |
| Trade debts | 44 | €124,382 | €119,534 | -€4,848 | -3.9% |
| Suppliers | 440/4 | €124,382 | €119,534 | -€4,848 | -3.9% |
| Taxes, remuneration and social security | 45 | €52,010 | €63,151 | +€11,142 | +21.4% |
| Taxes | 450/3 | €33,011 | €37,844 | +€4,833 | +14.6% |
| Remuneration and social security | 454/9 | €18,998 | €25,307 | +€6,309 | +33.2% |
| Other amounts payable | 47/48 | €257,533 | €15,881 | -€241,652 | -93.8% |
| Accrued charges and deferred income | 492/3 | €15,300 | - | -€15,300 | |
| Remuneration, social security and pensions | 62 | €205,581 | €243,487 | +€37,905 | +18.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €145,207 | €133,949 | -€11,258 | -7.8% |
| Other operating charges | 640/8 | €1,826 | €720 | -€1,107 | -60.6% |
| Gross operating margin | 9900 | €563,105 | €821,455 | +€258,350 | +45.9% |
| Operating profit (loss) | 9901 | €210,490 | €443,299 | +€232,809 | +111% |
| Financial income | 75/76B | €1,073 | €2,314 | +€1,241 | +116% |
| Recurring financial income | 75 | €1,073 | €2,314 | +€1,241 | +116% |
| Financial charges | 65/66B | €56,260 | €37,267 | -€18,993 | -33.8% |
| Recurring financial charges | 65 | €56,260 | €37,267 | -€18,993 | -33.8% |
| Profit (loss) for the period before taxes | 9903 | €155,303 | €408,346 | +€253,043 | +163% |
| Income taxes | 67/77 | €59,397 | €139,540 | +€80,143 | +135% |
| Profit (loss) for the period | 9904 | €95,906 | €268,806 | +€172,900 | +180% |
| Profit (loss) for the period to be appropriated | 9905 | €95,906 | €268,806 | +€172,900 | +180% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.